Step 1: Understanding the Concept:
Reserved antibiotics (often part of the WHO "AWaRe" classification) are high-priority antibiotics that are considered the "last resort" for treatment.
Step 2: Detailed Explanation:
1. Preservation: The primary public health goal of "reserving" these drugs is to prevent the development of antimicrobial resistance (AMR). By limiting their use, we ensure that bacteria are not frequently exposed to them, keeping them effective for as long as possible.
2. Clinical Use: While they are indeed used for severe multidrug-resistant (MDR) infections, the policy of labeling them as "reserved" is specifically a strategy to prevent the emergence of resistance across the population.
3. Others: Using them for minor infections (Option A) is the exact opposite of the intended use and would accelerate resistance.
Step 3: Final Answer:
The "Reserve" category is a stewardship strategy intended to preserve the efficacy of last-resort antibiotics by preventing the selection pressure that leads to resistance.